BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8680731)

  • 1. Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta.
    Li Q; Zhang L; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1995 Dec; 116(7):2963-70. PubMed ID: 8680731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
    Li Q; Zhang J; Pfaffendorf M; van Zwieten PA
    Br J Pharmacol; 1996 Aug; 118(7):1653-8. PubMed ID: 8842428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin I, II, and II tachyphylaxis in the mesenteric vascular circuit of the rat.
    Fasciolo JC; Binia A
    Hypertension; 1981; 3(6 Pt 2):II-166-70. PubMed ID: 7028614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.
    Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
    Br J Pharmacol; 1995 Apr; 114(8):1599-604. PubMed ID: 7599928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y; Forster C
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat.
    Côrtes SF; Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1996 Dec; 119(8):1635-41. PubMed ID: 8982512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1993 Sep; 110(1):159-62. PubMed ID: 8220876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
    Briand V; Riva L; Galzin AM
    Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
    Adeagbo AS; Triggle CR
    Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan.
    Robertson MJ; Wragg A; Clark KL
    Regul Pept; 1994 Feb; 50(2):137-45. PubMed ID: 8190915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium enhances tachyphylaxis to angiotensins II and III in rat aorta.
    Gruetter CA; Ryan ET; Schoepp DD
    Eur J Pharmacol; 1987 Nov; 143(1):139-42. PubMed ID: 3691648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and III microinjections into the zona incerta influence drinking behavior.
    Bagi EE; Fekete E; Lénárd L
    Brain Res; 2003 Jul; 977(2):199-208. PubMed ID: 12834880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 angiotensin receptors mobilize intracellular calcium in a subclone of NG108-15 neuroblastoma cells.
    Ransom JT; Sharif NA; Dunne JF; Momiyama M; Melching G
    J Neurochem; 1992 May; 58(5):1883-8. PubMed ID: 1560241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature.
    Muller C; Endlich K; Helwig JJ
    Br J Pharmacol; 1998 Jul; 124(5):946-52. PubMed ID: 9692780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.